TOBI (tobramycin) 300 mg/5 mL nebuliser solution, 56 ampoules (Meda Pharma) Long-term treatment of chronic pulmonary infection caused by Pseudomonas aeruginosa Drug delivery from Europe, storage conditions observed. +380996042415 Viber, WhatsApp.
Indications for Tobi®
- Long-term treatment of chronic pulmonary infection caused by Pseudomonas aeruginosa (Pseudomonas aeruginosa) in patients with cystic fibrosis aged 6 years and older.
- Trade Name:Toby
- Chemical Name:Tobramycin
- Dosage:300 mg
- Quantity:56
- Form of Issue:Ampoule
No reviews yet